Nitrazepam Bristol Laboratories

Nitrazepam, the active ingredient in Nitrazepam Bristol Laboratories, is a benzodiazepine presented as a tablet for oral use. It is prescribed for insomnia, anxiety disorders and certain seizure conditions in adult patients.

GNH USA supplies Nitrazepam Bristol Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrazepam belongs to the benzodiazepine class and acts on the central nervous system to modify several neuro‑psychiatric conditions. - Insomnia: helps initiate and maintain sleep in patients with difficulty falling asleep. - Anxiety disorders: reduces excessive worry and tension in generalized anxiety. - Seizure disorders: provides adjunctive control of certain focal and generalized seizures.

Nitrazepam may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy during daytime. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate head pain. - Fatigue: reduced energy and motivation. - Muscle weakness: transient loss of strength. - Memory impairment: difficulty recalling recent events.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, particularly with other depressants. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Paradoxical agitation: increased anxiety or aggression. - Dependence or withdrawal: signs of physical dependence after prolonged use. - Depression or suicidal thoughts: mood changes requiring urgent evaluation. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

When prescribing nitrazepam, clinicians should consider several safety measures. - Dose adjustment: reduce dose in elderly or renally impaired patients. - Concomitant CNS depressants: avoid or monitor use with alcohol, opioids or antihistamines. - Pregnancy: use only if potential benefit outweighs risk; data are limited. - Breastfeeding: assess risk as drug may pass into milk. - Driving and machinery: advise patients not to operate vehicles until they know how the drug affects them. - Store at ambient temperature: keep below 25°C in original container, protect from moisture and light.

Nitrazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression. - Barbiturates: additive CNS depression can be life‑threatening. - Antifungal azoles (e.g., ketoconazole): may increase nitrazepam plasma levels.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance sedative effects. - Antihistamines: increase drowsiness. - Anticonvulsants (phenytoin, carbamazepine): may reduce nitrazepam effectiveness. - CYP3A4 inhibitors/inducers: alter drug metabolism, requiring dose review.